TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹17,686 Cr | ₹2,088 Cr | ₹2,224 Cr | ₹2,823 Cr | ₹2,238 Cr |
What is the latest Total Non-Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹17,686 Cr |
| Mar2025 | ₹2,088 Cr |
| Mar2024 | ₹2,224 Cr |
| Mar2023 | ₹2,823 Cr |
| Mar2022 | ₹2,238 Cr |
How is Total Non-Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,686 Cr | 747.13 | |
| Mar2025 | ₹2,088 Cr | -6.13 | |
| Mar2024 | ₹2,224 Cr | -21.21 | |
| Mar2023 | ₹2,823 Cr | 26.12 | |
| Mar2022 | ₹2,238 Cr | - | |
Compare Total Non-Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹190,922.8 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| MANKIND PHARMA | ₹102,194.0 Cr | -5.5% | -2.2% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.4% |
5.3% |
41.7% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses